A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
Clinical trial NCT02336139 · COMPLETED
Trial details
- NCT number
- NCT02336139
- Sponsor
- Kirby Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-16
- Primary completion
- 2017-04-17
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.